There is no generic version of Trulance (chemical name: caxibacumab) currently available. Trulance is a brand-name medication manufactured by Astellas Pharma and Pfizer.
When might a generic version of Trulance become available?
The availability of generic versions of a drug is typically tied to patent expirations and market exclusivity periods. Information regarding the specific patents for Trulance and their expiration dates can be found on resources like DrugPatentWatch.com [1]. Without a generic competitor, Trulance remains the sole option for its indicated uses, affecting its price and accessibility.
What is Trulance used to treat?
Trulance is an oral medication prescribed for adults with moderate to severe chronic idiopathic constipation (CIC) [2]. It is also used for adults with irritable bowel syndrome with constipation (IBS-C) [2].
How does Trulance work?
Trulance activates guanylate cyclase-C (GC-C) on the surface of intestinal epithelial cells [2]. This activation increases fluid secretion into the intestinal lumen and accelerates intestinal transit, which helps to soften stool and promote bowel movements [2].
What are the potential side effects of Trulance?
The most common side effects reported for Trulance include diarrhea [2]. Patients experiencing diarrhea should consult their healthcare provider, as it can sometimes be severe [2].
What are the alternatives to Trulance for constipation?
Other treatment options for chronic constipation can include dietary changes, increased fluid intake, exercise, over-the-counter laxatives, and prescription medications. The choice of treatment depends on the underlying cause and severity of the constipation.
Where can I find more information on drug patents?
DrugPatentWatch.com provides comprehensive data on drug patents, including expiration dates, litigation, and generic availability for various medications [1].
*
**Sources:
[1] DrugPatentWatch.com
[2] Trulance prescribing information